Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Home-based electrical stimulation and training for walking after chronic stroke

Tests home functional electrical stimulation with task training in adults with chronic stroke.

Plain-language title generated from the registry record
Registry title: Home-based FES Training in People With Chronic Stroke

Key facts

Where
Chicago, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 90 years old?

Source: NCT05849532, who can take part

Where in United States

  • University of Illinois at ChicagoChicago, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Illinois Chicago
Trial code
NCT05849532
Record updated
8 July 2026
Original description
This project will examine the feasibility, safety and effect of home-based functional electrical stimulation (FES) applied to different lower limb muscles in combination with task-specific training on gait, balance and mobility in adults with chronic stroke. 30 individuals with chronic stroke will first undergo initial screening and baseline walking, mobility, balance and strength assessments in the laboratory. After determining their eligibility for the study, they will undergo 12-weeks of home-based FES and task-specific training. Following the initial screening (week 1) and pre-intervention assessment (week 2), participants will be trained in the lab for 6 sessions (week 3-4) for a FES home program and then given a FES home kit (FES device and an android tablet). Participants will then undergo home-training for 2 weeks (week 5-6) followed by mid-training assessment (week 7). Again, participants will undergo 4-weeks of home training (week 8-11) and final assessment at the end of training (week 12).Read full original descriptionShow less

Feasibility and Efficacy of Home-Based Functional Electrical Stimulation and Task-Specific Training in Adults With Chronic Stroke

This project will examine the feasibility, safety and effect of home-based functional electrical stimulation (FES) applied to different lower limb muscles in combination with task-specific training on gait, balance and mobility in adults with chronic stroke. 30 individuals with chronic stroke will first undergo initial screening and baseline walking, mobility, balance and strength assessments in the laboratory. After determining their eligibility for the study, they will undergo 12-weeks of home-based FES and task-specific training. Following the initial screening (week 1) and pre-intervention assessment (week 2), participants will be trained in the lab for 6 sessions (week 3-4) for a FES home program and then given a FES home kit (FES device and an android tablet). Participants will then undergo home-training for 2 weeks (week 5-6) followed by mid-training assessment (week 7). Again, participants will undergo 4-weeks of home training (week 8-11) and final assessment at the end of training (week 12).

This project has the following specific aims:

Aim 1: To investigate the feasibility, safety and efficacy of 12-weeks of home-based FES and task-specific training in adults with chronic stroke.

Aim 2: To examine the effect of 12-weeks of home-based FES and task-specific training on mobility, gait and balance (anticipatory and reactive balance) in adults with chronic stroke.

Inclusion: Age group: 18-90 years; Presence of unilateral hemiparesis; Onset of stroke (> 6 months); Ability to walk independently with or without an assistive device for at least 300 ft; Can understand and communicate in English and can verbalize discomfort or pain in English; Use of smartphone on a daily basis; Availability of internet/Wi-Fi at home.

Exclusion: Recent major surgery (< 6 months) or hospitalization (< 3 months); Cognitive impairment (Montreal Cognitive assessment score <26/30); Any neurological condition other than stroke; Uncontrolled and/or untreated hypertension/hypotension, uncontrolled and/or untreated diabetes and any musculoskeletal, neuromuscular or systemic diagnosis ; Deep venous thrombosis; Past or current history of any type of active cancer; Uncontrolled high blood pressure/angina; Skin condition not tolerant with FES therapy; Past or current history of uncontrolled/controlled epilepsy or any other types of seizure disorders; Body weight more than 250 lbs; Heel bone density measurement using an ultrasound device. Individuals classified as osteoporotic (i.e., with a T-score < -2) will be excluded; Verbal Aphasia (i.e <71% score on Mississippi Aphasia Screening); Severe depression (> 15 points on geriatric depression scale); Peripheral nerve injury or neuropathy in the affected limb with motor disability; Botox treatment within the last 5 months; Pacemaker users; -.

ClinicalTrials.gov NCT05849532